AP2015008459A0 - Stable preservative-free mydriatic and anti-inflammatory solutions for injection - Google Patents

Stable preservative-free mydriatic and anti-inflammatory solutions for injection

Info

Publication number
AP2015008459A0
AP2015008459A0 AP2015008459A AP2015008459A AP2015008459A0 AP 2015008459 A0 AP2015008459 A0 AP 2015008459A0 AP 2015008459 A AP2015008459 A AP 2015008459A AP 2015008459 A AP2015008459 A AP 2015008459A AP 2015008459 A0 AP2015008459 A0 AP 2015008459A0
Authority
AP
ARIPO
Prior art keywords
injection
stable preservative
mydriatic
free
inflammatory
Prior art date
Application number
AP2015008459A
Other languages
English (en)
Inventor
Clark E Tedford
Hui-Rong Shen
Gregory A Demopulos
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50545210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008459(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of AP2015008459A0 publication Critical patent/AP2015008459A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/08Mydriatics or cycloplegics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AP2015008459A 2012-10-24 2013-10-23 Stable preservative-free mydriatic and anti-inflammatory solutions for injection AP2015008459A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718026P 2012-10-24 2012-10-24
US201261736179P 2012-12-12 2012-12-12
PCT/US2013/066349 WO2014066485A1 (en) 2012-10-24 2013-10-23 Stable preservative-free mydriatic and anti-inflammatory solutions for injection

Publications (1)

Publication Number Publication Date
AP2015008459A0 true AP2015008459A0 (en) 2015-05-31

Family

ID=50545210

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008459A AP2015008459A0 (en) 2012-10-24 2013-10-23 Stable preservative-free mydriatic and anti-inflammatory solutions for injection

Country Status (39)

Country Link
US (6) US9066856B2 (en, 2012)
EP (2) EP3909572B1 (en, 2012)
JP (8) JP6017053B2 (en, 2012)
KR (4) KR20170128640A (en, 2012)
CN (2) CN108721210A (en, 2012)
AP (1) AP2015008459A0 (en, 2012)
AR (1) AR093115A1 (en, 2012)
AU (1) AU2013201465B2 (en, 2012)
BR (1) BR112015009228B1 (en, 2012)
CA (1) CA2887772C (en, 2012)
CL (1) CL2015001078A1 (en, 2012)
CR (1) CR20150233A (en, 2012)
CU (1) CU20150037A7 (en, 2012)
CY (1) CY1124481T1 (en, 2012)
DK (1) DK2911511T3 (en, 2012)
EA (1) EA033811B1 (en, 2012)
ES (1) ES2875432T3 (en, 2012)
GE (1) GEP20186891B (en, 2012)
HR (1) HRP20210980T1 (en, 2012)
HU (1) HUE055537T2 (en, 2012)
IL (1) IL238439B2 (en, 2012)
IN (1) IN2015DN03029A (en, 2012)
LT (1) LT2911511T (en, 2012)
MA (1) MA38096B1 (en, 2012)
MD (1) MD20150050A2 (en, 2012)
MX (2) MX382411B (en, 2012)
MY (2) MY188474A (en, 2012)
NZ (1) NZ628398A (en, 2012)
PE (1) PE20150958A1 (en, 2012)
PH (1) PH12015500850B1 (en, 2012)
PL (1) PL2911511T3 (en, 2012)
PT (1) PT2911511T (en, 2012)
RS (1) RS62188B1 (en, 2012)
SG (1) SG11201502602WA (en, 2012)
SI (1) SI2911511T1 (en, 2012)
SM (1) SMT202100393T1 (en, 2012)
UA (1) UA114650C2 (en, 2012)
WO (1) WO2014066485A1 (en, 2012)
ZA (1) ZA201502684B (en, 2012)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004010894A2 (en) 2002-07-30 2004-02-05 Omeros Corporation Ophthalmologic irrigation solutions and method
AU2013201465B2 (en) * 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US20210346318A1 (en) * 2013-10-03 2021-11-11 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
JP2016532723A (ja) 2013-10-03 2016-10-20 インプリミス・ファーマシューティカルズ・インコーポレイテッドImprimis Pharmaceuticals, Inc. 眼内投与のためのエピネフリン系点眼用組成物及びその製造のための方法
TWI809304B (zh) * 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
CN104856990A (zh) * 2015-05-07 2015-08-26 武汉武药科技有限公司 去氧肾上腺素酮咯酸溶液及制备方法
US11213480B1 (en) 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
USD831868S1 (en) 2015-09-17 2018-10-23 Lume Cube, Inc. Compact external light
US10704745B2 (en) 2015-10-13 2020-07-07 Lume Cube, Inc. Mobile light source
JP2019524896A (ja) 2016-08-25 2019-09-05 ハーロウ・ヘルス・インコーポレイテッドHarrow Health, Inc. 眼内投与のためのエピネフリンベースの眼科組成物及びその製造方法
US20180318319A1 (en) * 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
JP7078843B2 (ja) * 2018-03-26 2022-06-01 サミー株式会社 遊技機
KR20210096096A (ko) * 2018-10-26 2021-08-04 오큐파이어 파마, 인크. 노안, 산동, 및 기타 안구 장애의 치료를 위한 방법 및 조성물
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
DE102019125430B3 (de) 2019-09-20 2020-11-19 Carl Zeiss Meditec Ag Steuerungsvorrichtung für ein ophthalmochirurgisches System, ophthalmochirurgisches System sowie Computerprogrammprodukt
KR102749980B1 (ko) 2020-01-02 2025-01-03 삼성전자주식회사 에어 스페이서를 가지는 반도체 소자
US20210228507A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine Hydrochloride Compositions and Containers
WO2022132567A1 (en) * 2020-12-17 2022-06-23 Harrow Ip, Llc Mydriatic compositions and methods for fabricating thereof
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法
US11793789B2 (en) 2021-07-23 2023-10-24 Somerset Therapeutics, Llc Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine
US12029729B2 (en) 2021-07-23 2024-07-09 Somerset Therapeutics, Llc Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
WO2024086268A1 (en) * 2022-10-19 2024-04-25 Fresenius Kabi Austria Gmbh Phenylephrine liquid formulations
CN115950992B (zh) * 2023-03-15 2023-06-09 苏州朗易生物医药研究有限公司 一种去氧肾上腺素酮咯酸溶液中有关物质的检测方法及其应用
WO2025165753A1 (en) * 2024-01-31 2025-08-07 Hikma Pharmaceuticals Usa Inc. Pharmaceutical formulations of phenylephrine and process of making the same

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402949A (en) 1979-11-12 1983-09-06 Sandoz Ltd. Stable solutions of hydrogenated ergotalkaloids
US4550022A (en) 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
JPS58126810A (ja) 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
JPS6017053U (ja) 1983-07-11 1985-02-05 住友電気工業株式会社 伝送エラ−検出器
WO1987007141A1 (en) 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Method for treating glaucoma
US5212196A (en) 1986-10-21 1993-05-18 Alcon Laboratories, Inc. Control of post-surgical intraocular pressure using clonidine derivatives
US4938970A (en) 1987-02-06 1990-07-03 Hustead Robert E Painless electrolyte solutions
US5110493A (en) 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4876250A (en) 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
DE3833893A1 (de) 1988-10-05 1990-04-12 Bayer Ag Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte
US5036046A (en) 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5051443A (en) 1988-10-12 1991-09-24 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5371078A (en) 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
ATE135216T1 (de) 1989-08-21 1996-03-15 Beth Israel Hospital Verwendung von spiperone-derivate zur immunosuppression
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
CA2073003A1 (en) 1990-09-07 1992-03-08 Universidad De Alicante Composition for treating ocular pain
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
IT1252692B (it) 1991-11-27 1995-06-23 Zambon Spa Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
CA2126093A1 (en) 1992-10-21 1994-04-28 Owen Gan Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
US6117907A (en) 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
CA2149657A1 (en) 1993-09-29 1995-04-06 Billie M. York Compositions containing growth factors and antiplastic agents
WO1995009003A1 (en) 1993-09-29 1995-04-06 Alcon Laboratories, Inc. Compositions containing growth factors and antimetabolites
US5624893A (en) 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
AU1399695A (en) 1993-12-17 1995-07-03 Alcon Laboratories, Inc. Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
US6350781B1 (en) 1994-01-14 2002-02-26 Lee Shahinia, Jr. Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine
WO1995034298A1 (en) 1994-06-10 1995-12-21 Telor Ophthalmic Pharmaceuticals, Inc. Inhibition of intraoperative miosis/production of mydriasis by local anesthetics
US5523316A (en) 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ,インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
WO2000023072A1 (en) 1998-10-20 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
KR100517210B1 (ko) 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
EP2301562B1 (en) 1994-12-12 2013-04-17 Omeros Corporation Irrigation solution and method for inhibition of pain, inflammation and spasm
WO2000023061A2 (en) 1998-10-21 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5767105A (en) 1995-05-03 1998-06-16 Peyman; Gholam A. Ocular solution
US5798356A (en) 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6280745B1 (en) 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
WO1998004171A1 (en) 1996-07-26 1998-02-05 Schein Dental Equipment Co. Armrest mechanism for dental chairs
GB9704352D0 (en) 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US6030974A (en) 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6034256A (en) 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6495598B1 (en) 1997-04-22 2002-12-17 Ophtecs Corporation Perfusate preparation for ophthalmic operation
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
WO2000001379A1 (en) 1998-07-01 2000-01-13 Warner-Lambert Company (-)-pseudoephedrine as a sympathomimetic drug
JP2002520355A (ja) 1998-07-14 2002-07-09 アルコン ラボラトリーズ, インコーポレイテッド 非アレルギー性眼炎症障害を処置および眼新生血管形成を予防する医薬製造のための、11−(3−ジメチルアミノプロピリデン)−6,11−ジヒドロジベンズ[b,e]オキセピン−2−酢酸の使用
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
FR2782721B1 (fr) 1998-09-01 2000-11-03 Inst Nat Sante Rech Med Nouveaux composes phosphohalohydrines, procede de fabrication et applications
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1434573A2 (en) 1998-10-20 2004-07-07 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1227807B1 (en) 1998-10-20 2005-03-30 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
EP1206275B1 (en) 1998-11-05 2007-09-05 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
AU3119100A (en) 1998-12-17 2000-07-03 Alcon Laboratories, Inc. Methods for the prevention and treatment of post-surgical complications
RU2286157C2 (ru) * 1999-03-02 2006-10-27 Витрио-Ретинол Текнолоджиз, Инк. Средства для введения в стекловидное тело для лечения или предотвращения заболеваний глаз
CN1353573A (zh) 1999-05-14 2002-06-12 加利福尼亚大学董事会 对炎症介导感染的抗炎症治疗
CA2388828A1 (en) 1999-10-22 2001-06-14 Transdermatech, Inc. Topical anesthetic formulation
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
KR20030060771A (ko) 2000-04-28 2003-07-16 메모리얼 슬로안-케터링 캔서 센터 국소용 마취제/아편양약물 제제 및 이들의 용도
WO2002005848A2 (en) 2000-07-13 2002-01-24 Pharmacia Corporation Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
PE20020146A1 (es) 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
PL361027A1 (en) 2000-07-14 2004-09-20 Allergan,Inc. Compositions containing therapeutically active components having enhanced solubility
MXPA03000729A (es) 2000-07-28 2004-11-01 Inspire Pharmaceuticals Inc Metodo para reducir la presion intraocular utilizando derivados de indol.
JP2002161032A (ja) 2000-09-14 2002-06-04 Taisho Pharmaceut Co Ltd 粘膜適用組成物
CN1390124A (zh) 2000-09-20 2003-01-08 永光制药有限公司 近视眼的预防、治疗药
US20020183279A1 (en) 2001-04-18 2002-12-05 Koichiro Tanaka Pharmaceutical composition containing viscoelastic substance and medication
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
WO2004010894A2 (en) 2002-07-30 2004-02-05 Omeros Corporation Ophthalmologic irrigation solutions and method
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
MX2007007613A (es) 2004-12-22 2007-08-03 Schering Corp Formulaciones farmaceuticas.
CN101083984B (zh) 2004-12-23 2010-11-10 罗克斯罗制药公司 用于经鼻内投与酮咯酸(ketorolac)的治疗组合物
FR2882930B1 (fr) 2005-03-09 2009-03-27 Walid Katib Nouvelles compositions ophtalmologiques et leur mode d'utilisation
DOP2007000055A (es) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
WO2009026473A2 (en) 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
AU2008325214A1 (en) 2007-11-08 2009-05-14 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2009074853A2 (en) 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
CA2754266A1 (en) * 2009-03-06 2010-09-10 Medimmune, Llc Humanized anti-cd19 antibody formulations
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
CA2764473A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations of fluticasone and methods of use
JP2012528888A (ja) * 2009-06-05 2012-11-15 アーシエックス セラピューティックス, インコーポレイテッド 眼科用配合剤、その製造方法およびその使用方法
US8680510B2 (en) 2010-06-28 2014-03-25 International Business Machines Corporation Method of forming compound semiconductor
WO2012016000A2 (en) 2010-07-29 2012-02-02 Allergan, Inc. Preservative free brimonidine and timolol solutions
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Also Published As

Publication number Publication date
EP2911511A1 (en) 2015-09-02
SI2911511T1 (sl) 2021-09-30
LT2911511T (lt) 2021-07-26
RS62188B1 (sr) 2021-08-31
HRP20210980T1 (hr) 2021-09-17
KR20150068990A (ko) 2015-06-22
EP3909572B1 (en) 2025-08-06
KR20170128640A (ko) 2017-11-22
MY188474A (en) 2021-12-13
CL2015001078A1 (es) 2015-09-04
JP2023041804A (ja) 2023-03-24
JP2020147606A (ja) 2020-09-17
EA201590807A1 (ru) 2015-11-30
JP2018058905A (ja) 2018-04-12
KR102496463B1 (ko) 2023-02-06
US20150342928A1 (en) 2015-12-03
KR20210018954A (ko) 2021-02-18
PT2911511T (pt) 2021-07-06
US20220175726A1 (en) 2022-06-09
CN108721210A (zh) 2018-11-02
NZ628398A (en) 2016-03-31
US20140235691A1 (en) 2014-08-21
US12133842B2 (en) 2024-11-05
MX2020012591A (es) 2022-11-04
IL238439A0 (en) 2015-06-30
MY204103A (en) 2024-08-07
EA033811B1 (ru) 2019-11-27
JP2015535250A (ja) 2015-12-10
PH12015500850A1 (en) 2015-06-22
AU2013201465A1 (en) 2014-05-08
US9486406B2 (en) 2016-11-08
JP2025019330A (ja) 2025-02-06
US9855246B2 (en) 2018-01-02
MA38096A1 (fr) 2016-10-31
BR112015009228A8 (pt) 2022-07-12
SG11201502602WA (en) 2015-05-28
JP2016196511A (ja) 2016-11-24
EP2911511A4 (en) 2015-12-16
IL238439B1 (en) 2023-07-01
JP2019081798A (ja) 2019-05-30
PL2911511T3 (pl) 2021-11-15
US20170196838A1 (en) 2017-07-13
EP3909572A1 (en) 2021-11-17
CA2887772C (en) 2017-02-21
US20250032452A1 (en) 2025-01-30
CN104822265A (zh) 2015-08-05
SMT202100393T1 (it) 2021-09-14
BR112015009228B1 (pt) 2022-07-19
PE20150958A1 (es) 2015-07-09
GEP20186891B (en) 2018-09-10
MD20150050A2 (ro) 2015-09-30
HK1213434A1 (en) 2016-07-08
JP6017053B2 (ja) 2016-10-26
CR20150233A (es) 2015-08-14
MX2015005089A (es) 2015-07-17
KR102211784B1 (ko) 2021-02-04
WO2014066485A1 (en) 2014-05-01
JP2017014294A (ja) 2017-01-19
KR20200000487A (ko) 2020-01-02
AR093115A1 (es) 2015-05-20
BR112015009228A2 (pt) 2017-07-04
UA114650C2 (uk) 2017-07-10
KR101808394B1 (ko) 2017-12-12
US9066856B2 (en) 2015-06-30
AU2013201465B2 (en) 2016-03-03
ZA201502684B (en) 2016-01-27
MA38096B1 (fr) 2019-12-31
CA2887772A1 (en) 2014-05-01
PH12015500850B1 (en) 2017-11-17
ES2875432T3 (es) 2021-11-10
US20180085349A1 (en) 2018-03-29
MX382411B (es) 2025-03-13
IN2015DN03029A (en, 2012) 2015-10-02
EP2911511B1 (en) 2021-04-14
DK2911511T3 (en) 2021-06-28
HUE055537T2 (hu) 2021-12-28
JP6282699B2 (ja) 2018-02-21
CY1124481T1 (el) 2022-07-22
IL238439B2 (en) 2023-11-01
CU20150037A7 (es) 2015-08-27

Similar Documents

Publication Publication Date Title
DK2911511T3 (en) Stable Preservative-Free Mydriatic and Anti-Inflammatory Solutions for Injection
DK3278792T3 (da) Lægemiddelformulering med forsinket udløsning
ZA201406233B (en) Pharmaceutical composition and administration thereof
AU343318S (en) Medicine injector
EP2814996A4 (en) NOZZLE AND NOZZLE HEAD
EP2776115A4 (en) MEDICAL PLASTER AND INJECTOR SYSTEM
EP2685965A4 (en) COMBINED FORMULATION WITH INCREASED STABILITY
PL2870072T3 (pl) Dozownik leków
PL2833945T3 (pl) Wstrzykiwacz typu „pen”
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2885028A4 (en) DISPOSABLE INJECTOR
ZA201405949B (en) Pharmaceutical preparation containing and antivirally active dihydroquinazoline derivative
GB201504945D0 (en) Absobent article with highlighted active barrier
IL235131A0 (en) dispenses medicine
EP2878780A4 (en) INJECTION NOZZLE FOR A UREA SOLUTION
IL230779A0 (en) Stable anti-inflammatory solutions for injection
AP2015008208A0 (en) Pharmaceutical administration forms comprising
IL229591A0 (en) Addition of medicine
EP2700454B8 (en) Injection nozzle
PL2852537T3 (pl) Torebka do zaparzania i jej wytwarzanie
GB201202938D0 (en) Improvements relating to medicament delivery devices
ZA201405925B (en) Pharmaceutical formulation having improved stability
EP2848272A4 (en) INJEKTOR
EP2934847B8 (en) Nozzle tip
IL220794A (en) Medication dispenser